A designed equine herpes thymidine kinase (EHV4 TK) variant improves 
ganciclovir-induced cell-killing.

McSorley, T.; Ort, S.; Monnerjahn, C.; Konrad, M.

doi:10.1016/j.bcp.2013.11.011

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing.

MPS-Authors

/persons/resource/persons15362

Konrad, M.
Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://www.sciencedirect.com/science/article/pii/S0006295213007429/pdfft?md5=5d5723f70eb409b2dd89afb06035d56f&pid=1-s2.0-S0006295213007429-main.pdf
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

1938019.pdf
(Publisher version), 3MB

Supplementary Material (public)

There is no public supplementary material available

Citation

McSorley, T., Ort, S., Monnerjahn, C., & Konrad, M. (2014). A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing. Biochemical Pharmacology, 87(3), 435-444. doi:10.1016/j.bcp.2013.11.011.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0015-8268-F

Abstract

The limitations of the ganciclovir (GCV)/herpes simplex virus thymidine kinase (HSV1 TK: EC 2.7.1.21) system as a suicide gene therapy approach have been extensively studied over the years. In our study, we focused on improving the cytotoxic profile of the GCV/equine herpes virus-4 thymidine kinase (EHV4 TK: EC 2.7.1.21) system. Our approach involved the structure-guided mutagenesis of EHV4 TK in order to switch its ability to preferentially phosphorylate the natural substrate deoxythymidine (dT) to that of GCV. We performed steady-state kinetic analysis, genetic complementation in a thymidine kinase-deficient Escherichia coli strain, isothermal titration calorimetry, and analysis of GCV-induced cell killing through generation of HEK 293 stable cell-lines expressing EHV4 TK mutants and wild-type EHV4 TK. We found that the EHV4 TK S144H-GFP mutant preferentially phosphorylates GCV and confers increased GCV-induced cytotoxicity compared to wild-type EHV4 TK.